AstraZeneca said on Sunday the Egyptian Drug Authority has granted an emergency use authorization of AstraZeneca’s ‘Evusheld’ pill.
AstraZeneca said that the first doses of the drug are expected to become available in Egypt in the coming weeks.
Recent clinical trials showed Evusheld recipients at increased risk of severe COVID-19 infection saw a 77% reduced risk of developing COVID-19.
Several countries have granted its authorization, including France and the US.
add your comment
Terms of publication : Not to offend the writer, people, sacred things, or attack religions or the divine self, and refrain from racist incitement and insults.